Dr. Kiki's Science Hour 36
Guest: Andrew Read
Recorded: March 4, 2010
Published: March 8, 2010
Andrew Read, Penn State University, Professor of Biology and Entomology, and Eberly College of Science Distinguished Senior Scholar
Battling the Red Queen Dr. Kiki talks with Andrew Read about the arms race between human drugs and the evolution of infectious diseases. Is it possible to get out of the evolutionary race where infectious diseases and drug development are concerned?
Arteminisins are the most effective drugs we currently have to combat malaria. This past year, scientists learned that the malaria parasite had developed resistance to the drugs in some areas of the world. Now the question facing the health industry is how they minimize the spread of the resistant strains to allow the drugs to last longer... how can they buy scientists time to create a new drug? This is just one example of the situation we face, which will simply go on and on and on, unless we can derail the process somehow.
Can we stop the mad dash to create the next drug that will only work as long as diseases are not resistant? Can we use evolutionary principles to get around evolution?
- Evolution and virulence
- Interactions between pathogens
- Phylodynamics and the evolution of immunity
- Control strategies
- Edited by: Erik
|This area is for use by TWiT staff only. Please do not add or edit any content within this section.|